AzTrials
AzTrials

Atelectasis, Postoperative PulmonaryNCT03943433

Oxygen Concentration During Alveolar Recruitment

A study testing FiO2_1.0 and FiO2_0.4 in people with Atelectasis, Postoperative Pulmonary, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to investigate the effect of oxygen concentration during alveolar recruitment on absorption ateletasis. Read more about this study

Who is it for?
Ages 20 to 70 years
Conditions the study is for
Atelectasis, Postoperative Pulmonary
What is being tested?
FiO2_1.0 and FiO2_0.4
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteSouth Korea
Study dates
15 May 2019to 10 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients undergoing laparoscopic obstetric or colon surgery with Trendelenburg position

Who cannot join

  • American Society of Anesthesiologists physical status IV or more
  • Severe cardiovascular disease
  • Severe chronic obstructive pulmonary disease, emphysema
  • History of pneumothorax, bullae
  • History of lung resection surgery
  • Conversion to laparotomy
  • Refusal to participate

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Hospital

    Seoul, 110-744

Other trials in South Korea

About this study

Official title: The Effect of Oxygen Concentration During Alveolar Recruitment on Absorption Atelectasis

The purpose of this study is to investigate the effect of oxygen concentration during alveolar recruitment on absorption ateletasis.

Being tested
FiO2_1.0, FiO2_0.4
Keywords
Absorption atelectasis, Lung sono, Oxygen concentration
Medical subject headings
Pulmonary Atelectasis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FiO2_1.0Procedure or surgery

    Alveolar recruitment is performed with 100% oxygen concentration after general anesthesia induction, after position change to Trendelenburg, after position change to supine, and at the end of operation.

  • FiO2_0.4Procedure or surgery

    Alveolar recruitment is performed with 40% oxygen concentration after general anesthesia induction, after position change to Trendelenburg, after position change to supine, and at the end of operation.

Study groups in NCT03943433
Study groupRoleWhat they receive
FiO2_1.0Active comparatorAlveolar recruitment is performed with 100% oxygen concentration at specific time points.
Receives: Procedure: FiO2_1.0
FiO2_0.4ExperimentalAlveolar recruitment is performed with 40% oxygen concentration at specific time points.
Receives: Procedure: FiO2_0.4

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Modified lung ultrasound score

    The score is calculated by adding up the 12 individual quadrant scores assessed using lung ultrasound. Each quadrant score ranges from 0 (minimal atelectasis)~3 (severe atelectasis), so the maximum total score is 36.

    Measured: Intraoperative (at the end of operation, before emergence)

Secondary outcomes (5)
  1. Modified lung ultrasound score

    The score is calculated by adding up the 12 individual quadrant scores assessed using lung ultrasound. Each quadrant score ranges from 0 (minimal atelectasis)~3 (severe atelectasis), so the maximum total score is 36.

    Measured: Postoperative 30 minutes

  2. Intraoperative desaturation

    Oxygen saturation by pulse oximetry <95%

    Measured: Intraoperative

  3. Intraoperative partial pressure of arterial oxygen/fraction of inspired oxygen ratio

    Partial pressure of arterial oxygen/fraction of inspired oxygen ratio

    Measured: Intraoperative (20minutes after each recruitment)

  4. Postoperative partial pressure of arterial oxygen/fraction of inspired oxygen ratio

    Partial pressure of arterial oxygen/fraction of inspired oxygen ratio

    Measured: Postoperative 30 minutes

  5. Postoperative pulmonary complication

    respiratory infection, respiratory failure, pleural effusion, atelectasis, pneumothorax, atelectasis, bronchospasm, aspiration pneumonitis

    Measured: Postoperative 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 May 2019
  2. Study start15 May 2019
  3. Primary completion20 Mar 2020
  4. Study completion10 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03943433
Sponsor's protocol ID
JHBahk_AR
Status last verified
Jul 2020
First submitted
7 May 2019
Last updated
14 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kim BR, Lee S, Bae H, Lee M, Bahk JH, Yoon S. Lung ultrasound score to determine the effect of fraction inspired oxygen during alveolar recruitment on absorption atelectasis in laparoscopic surgery: a randomized controlled trial. BMC Anesthesiol. 2020 Jul 18;20(1):173. doi: 10.1186/s12871-020-01090-y.

    PubMed 32682397

Questions about this trial

What is this clinical trial studying?

A study testing FiO2_1.0 and FiO2_0.4 in people with Atelectasis, Postoperative Pulmonary, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Modified lung ultrasound score (time frame: Intraoperative (at the end of operation, before emergence)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03943433, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in